Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Fantin

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
The Journal of Infectious Diseases|July 1, 2009
Ciprofloxacin dosage and emergence of resistance in human commensal bacteriaBruno Fantin, Xavier Duval, Laurent Massias, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 27, 2005
Risk factors for Staphylococcus aureus infection in liver transplant recipientsFrédéric Bert, Claire Bellier, Ludovic Lassel, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2010
The in vitro contribution of autolysins to bacterial killing elicited by amoxicillin increases with inoculum size in Enterococcus faecalisVincent Dubée, Françoise Chau, Michel Arthur, et al.
Blood Cells, Molecules & Diseases|May 8, 2012
Ferritinemia during type 1 Gaucher disease: mechanisms and progression under treatmentArsène Mekinian, Jérôme Stirnemann, Nadia Belmatoug, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2006
Amoxicillin is effective against penicillin-resistant Streptococcus pneumoniae strains in a mouse pneumonia model simulating human pharmacokineticsPierre Abgueguen, Esther Azoulay-Dupuis, Violaine Noel, et al.
Orphanet Journal of Rare Diseases|July 2, 2014
Modeling changes in biomarkers in Gaucher disease patients receiving enzyme replacement therapy using a pathophysiological modelMarie Vigan, Jérôme Stirnemann, Catherine Caillaud, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 11, 2018
Ceftriaxone promotes the emergence of AmpC-overproducing Enterobacteriaceae in gut microbiota from hospitalized patientsVictoire de Lastours, Tiphaine Goulenok, François Guérin, et al.
Neurosurgery|November 15, 2008
Optimization of bacterial diagnosis yield after needle aspiration in immunocompetent adults with brain abscessesVictoire de Lastours, Michel Kalamarides, Véronique Leflon, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2002
Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureusBrigitte Malbruny, Annie Canu, Bülent Bozdogan, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditisJuliette Pavie, Agnès Lefort, Marie-Cécile Ploy, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
The Journal of Infectious Diseases|July 1, 2009
Ciprofloxacin dosage and emergence of resistance in human commensal bacteriaBruno Fantin, Xavier Duval, Laurent Massias, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 27, 2005
Risk factors for Staphylococcus aureus infection in liver transplant recipientsFrédéric Bert, Claire Bellier, Ludovic Lassel, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2010
The in vitro contribution of autolysins to bacterial killing elicited by amoxicillin increases with inoculum size in Enterococcus faecalisVincent Dubée, Françoise Chau, Michel Arthur, et al.
Blood Cells, Molecules & Diseases|May 8, 2012
Ferritinemia during type 1 Gaucher disease: mechanisms and progression under treatmentArsène Mekinian, Jérôme Stirnemann, Nadia Belmatoug, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2006
Amoxicillin is effective against penicillin-resistant Streptococcus pneumoniae strains in a mouse pneumonia model simulating human pharmacokineticsPierre Abgueguen, Esther Azoulay-Dupuis, Violaine Noel, et al.
Orphanet Journal of Rare Diseases|July 2, 2014
Modeling changes in biomarkers in Gaucher disease patients receiving enzyme replacement therapy using a pathophysiological modelMarie Vigan, Jérôme Stirnemann, Catherine Caillaud, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 11, 2018
Ceftriaxone promotes the emergence of AmpC-overproducing Enterobacteriaceae in gut microbiota from hospitalized patientsVictoire de Lastours, Tiphaine Goulenok, François Guérin, et al.
Neurosurgery|November 15, 2008
Optimization of bacterial diagnosis yield after needle aspiration in immunocompetent adults with brain abscessesVictoire de Lastours, Michel Kalamarides, Véronique Leflon, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2002
Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureusBrigitte Malbruny, Annie Canu, Bülent Bozdogan, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditisJuliette Pavie, Agnès Lefort, Marie-Cécile Ploy, et al.
Pageof 11